Abstract
In spite of increasing interest in cancer genetics relatively little knowledge is available pertaining to genetic markers. This review briefly discussed several genetic markers including G 6 PD and cytogenetic findings such as Philadelphia chromosome (PH1) in chronic myelogenous leukemia. The study also discusses the role of genetics in childhood cancer including population investigations such as the Oxford Survey of Childhood Cancers. In addition, a family with histologically verified cancer in two siblings (sarcoma of the thigh in the proband and medulloblastoma of the right cerebellum in a 6 yr old sister), sarcoma in their father, cancer of the liver by history in the 2 yr old paternal aunt of the proband, and histologically verified cancer in both paternal grandparents are discussed. This family serves as an example of the type of problem which may present to the cancer geneticist wherein no currently recognizable hereditary cancer syndrome exists which might be consistent with these findings. Thus while the familial aggregation of cancer in this particular family appears to be significant, one must attempt to determine other factors such as cytogenetics, genetic markers, and viral studies which might help elucidate etiology. (Lynch - Omaha, Nebr.)
| Original language | English |
|---|---|
| Pages (from-to) | 430-433 |
| Number of pages | 4 |
| Journal | The Nebraska medical journal |
| Volume | 58 |
| Issue number | 12 |
| State | Published - 1973 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Medicine(all)
Cite this
Cancer genetics, part III : genetic markers, childhood cancer problems. / Lynch, Henry T.
In: The Nebraska medical journal, Vol. 58, No. 12, 1973, p. 430-433.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Cancer genetics, part III
T2 - genetic markers, childhood cancer problems
AU - Lynch, Henry T.
PY - 1973
Y1 - 1973
N2 - In spite of increasing interest in cancer genetics relatively little knowledge is available pertaining to genetic markers. This review briefly discussed several genetic markers including G 6 PD and cytogenetic findings such as Philadelphia chromosome (PH1) in chronic myelogenous leukemia. The study also discusses the role of genetics in childhood cancer including population investigations such as the Oxford Survey of Childhood Cancers. In addition, a family with histologically verified cancer in two siblings (sarcoma of the thigh in the proband and medulloblastoma of the right cerebellum in a 6 yr old sister), sarcoma in their father, cancer of the liver by history in the 2 yr old paternal aunt of the proband, and histologically verified cancer in both paternal grandparents are discussed. This family serves as an example of the type of problem which may present to the cancer geneticist wherein no currently recognizable hereditary cancer syndrome exists which might be consistent with these findings. Thus while the familial aggregation of cancer in this particular family appears to be significant, one must attempt to determine other factors such as cytogenetics, genetic markers, and viral studies which might help elucidate etiology. (Lynch - Omaha, Nebr.)
AB - In spite of increasing interest in cancer genetics relatively little knowledge is available pertaining to genetic markers. This review briefly discussed several genetic markers including G 6 PD and cytogenetic findings such as Philadelphia chromosome (PH1) in chronic myelogenous leukemia. The study also discusses the role of genetics in childhood cancer including population investigations such as the Oxford Survey of Childhood Cancers. In addition, a family with histologically verified cancer in two siblings (sarcoma of the thigh in the proband and medulloblastoma of the right cerebellum in a 6 yr old sister), sarcoma in their father, cancer of the liver by history in the 2 yr old paternal aunt of the proband, and histologically verified cancer in both paternal grandparents are discussed. This family serves as an example of the type of problem which may present to the cancer geneticist wherein no currently recognizable hereditary cancer syndrome exists which might be consistent with these findings. Thus while the familial aggregation of cancer in this particular family appears to be significant, one must attempt to determine other factors such as cytogenetics, genetic markers, and viral studies which might help elucidate etiology. (Lynch - Omaha, Nebr.)
UR - http://www.scopus.com/inward/record.url?scp=0015712078&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0015712078&partnerID=8YFLogxK
M3 - Article
VL - 58
SP - 430
EP - 433
JO - The Nebraska medical journal
JF - The Nebraska medical journal
SN - 0091-6730
IS - 12
ER -